Fate Therapeutics Inc. buy Barclays PLC
Start price
14.05.25
/
50%
€0.86
Target price
14.05.26
€1.79
Performance (%)
49.12%
Price
08.10.25
€1.29
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Fate Therapeutics Inc. has seen massive gains of 49.12%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | 21.149% | 21.149% |
| iShares Core DAX® | 1.644% | 3.553% |
| iShares Nasdaq 100 | 2.211% | 6.941% |
| iShares Nikkei 225® | 3.718% | 6.703% |
| iShares S&P 500 | 1.557% | 5.211% |
Comments by Barclays_PLC for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Barclays PLC from $10.00 to $2.00. They now have an "overweight" rating on the stock.
Ratings data for FATE provided by MarketBeat
Stopped prediction by Barclays_PLC for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.42
27.02.24
27.02.24
€9.22
27.02.25
27.02.25
-81.86%
28.02.25
28.02.25
